← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 19, 2019Last known activity
Sep 30, 2025
Timeline
2010s
- Jan 1, 2013
Shanghai Cell Therapy Group Co.,Ltd— Founded
Drugs by trial phase (11 distinct, 13 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT07174843Lead sponsorEarly Phase 1Sep 30, 2025
- NCT07146672Lead sponsorPhase 1/Phase 2Jul 31, 2025
- NCT06732232Lead sponsorEarly Phase 1Dec 12, 2024
- NCT06446128Lead sponsorEarly Phase 1Apr 1, 2024
- NCT06036355Lead sponsorEarly Phase 1Sep 30, 2023
- NCT05944185Lead sponsorPhase 1/Phase 2Sep 30, 2023
- NCT06015269Lead sponsorPhase 1Aug 31, 2023
- NCT06248697Lead sponsorEarly Phase 1Jan 1, 2023
- NCT05089266Lead sponsorPhase 1Nov 30, 2021
- NCT05373147CollaboratorEarly Phase 1Oct 30, 2020
- NCT04489862CollaboratorEarly Phase 1May 13, 2020
- NCT04503980Lead sponsorEarly Phase 1Mar 26, 2020
- NCT04250324Lead sponsorPhase 1Nov 19, 2019
Details
- Founded
- Shanghai, CN Jan 1, 2013
- Last known activity
- Sep 30, 2025